Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

ANEB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 85.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Anebulo Pharmaceuticals Insider Trading History Chart

Anebulo Pharmaceuticals Share Price & Price History

^$1.59

▲ +0.07 (4.61%)

As of 11/15/2024 01:00 AM ET

Days: 30 | 90 | 365

Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?

From Golden Crest | Ad

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

Click Here For Your Free Guide

Anebulo Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
12/17/2021	Aron R. English	Insider	Buy	400	$6.59	$2,636.00
12/14/2021	Aron R. English	Insider	Buy	412	$5.89	$2,426.68
12/2/2021	Aron R. English	Insider	Buy	13,836	$5.30	$73,330.80

There is a little known company that is changing warfare

From Reticulate | Ad

With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t

SEC Filings (Institutional Ownership Changes) for Anebulo Pharmaceuticals (NASDAQ:ANEB)

28.40% of Anebulo Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Anebulo Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
1/16/2024	LVW Advisors LLC	643,039	$1.56M	0.3%	-4.4%	2.509%
2/8/2023	Herr Investment Group LLC	29,644	$72K	0.0%	N/A	0.116%
11/10/2022	Nantahala Capital Management LLC	511,073	$1.43M	0.1%	N/A	1.994%
10/14/2022	LVW Advisors LLC	674,964	$1.89M	0.4%	-3.6%	2.888%
7/22/2022	LVW Advisors LLC	700,000	$3.64M	0.7%	N/A	2.999%
8/18/2021	Ikarian Capital LLC	174,811	$1.20M	0.1%	N/A	0.749%
8/17/2021	22NW LP	3,343,565	$22.80M	6.1%	N/A	14.322%
8/17/2021	Boothbay Fund Management LLC	19,835	$0.14M	0.0%	N/A	0.085%
8/13/2021	Laurion Capital Management LP	225,000	$1.55M	0.0%	N/A	0.964%

Data available starting January 2016

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas.

Today's Range

Now: $1.59

$1.52

$1.59

50 Day Range

MA: $1.91

$1.48

$3.08

52 Week Range

Now: $1.59

$1.46

$3.30

Volume

2,443 shs

Average Volume

6,759 shs

Market Capitalization

$41.19 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

Get Your Free Gold Guide